BIOMAT Database Logo BIOMAT Database Logo

Non-nucleoside reverse transcriptase inhibitors (Part 18): synthesis and anti-HIV activity of 4-allylamino or 4-azido substituted diaryltriazines. 2009

Yuan-Zhen Xiong, and Hai-Rong Hu, and Fen-Er Chen, and Jan Balzarini, and Christophe Pannecouque, and Erik de Clercq
School of Pharmacy, Fudan University, Shanghai, China.

Eight new diaryltriazine derivatives containing 4-allylamino and 4-azido substitutes guided by molecular docking have been designed and synthesized based on our previous work. The evaluation of HIV inhibitory activity demonstrated that all compounds were potent against HIV-1 replication. The most active compound 7c exhibited activity against HIV-1 (IC50 = 0.034 micromol x L(-1), SI = 6,475) and the double mutant strain (IC50 = 9.39 micromol x L(-1)) in the micromolar range, which was more potent than nevirapine.

UI MeSH Term Description Entries
D014227 Triazines Heterocyclic rings containing three nitrogen atoms, commonly in 1,2,4 or 1,3,5 or 2,4,6 formats. Some are used as HERBICIDES. Triazine,Benzotriazines
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV
D020128 Inhibitory Concentration 50 The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture. IC50,Concentration 50, Inhibitory
D020134 Catalytic Domain The region of an enzyme that interacts with its substrate to cause the enzymatic reaction. Active Site,Catalytic Core,Catalytic Region,Catalytic Site,Catalytic Subunit,Reactive Site,Active Sites,Catalytic Cores,Catalytic Domains,Catalytic Regions,Catalytic Sites,Catalytic Subunits,Core, Catalytic,Cores, Catalytic,Domain, Catalytic,Domains, Catalytic,Reactive Sites,Region, Catalytic,Regions, Catalytic,Site, Active,Site, Catalytic,Site, Reactive,Sites, Active,Sites, Catalytic,Sites, Reactive,Subunit, Catalytic,Subunits, Catalytic

Related Publications

Yuan-Zhen Xiong, and Hai-Rong Hu, and Fen-Er Chen, and Jan Balzarini, and Christophe Pannecouque, and Erik de Clercq
Non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 11: structural modulations of diaryltriazines with potent anti-HIV activity.
June 2008, European journal of medicinal chemistry,
Yuan-Zhen Xiong, and Hai-Rong Hu, and Fen-Er Chen, and Jan Balzarini, and Christophe Pannecouque, and Erik de Clercq
Synthesis and anti-HIV activity of 2-naphthyl substituted DAPY analogues as non-nucleoside reverse transcriptase inhibitors.
July 2010, Bioorganic & medicinal chemistry,
Yuan-Zhen Xiong, and Hai-Rong Hu, and Fen-Er Chen, and Jan Balzarini, and Christophe Pannecouque, and Erik de Clercq
Design, synthesis, and anti-HIV activity of 4'-modified carbocyclic nucleoside phosphonate reverse transcriptase inhibitors.
February 2009, Bioorganic & medicinal chemistry,
Yuan-Zhen Xiong, and Hai-Rong Hu, and Fen-Er Chen, and Jan Balzarini, and Christophe Pannecouque, and Erik de Clercq
Improving the positional adaptability: structure-based design of biphenyl-substituted diaryltriazines as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
February 2020, Acta pharmaceutica Sinica. B,
Yuan-Zhen Xiong, and Hai-Rong Hu, and Fen-Er Chen, and Jan Balzarini, and Christophe Pannecouque, and Erik de Clercq
Synthesis, anti-HIV activity, and metabolic stability of new alkenyldiarylmethane HIV-1 non-nucleoside reverse transcriptase inhibitors.
September 2005, Journal of medicinal chemistry,
Yuan-Zhen Xiong, and Hai-Rong Hu, and Fen-Er Chen, and Jan Balzarini, and Christophe Pannecouque, and Erik de Clercq
Synthesis and anti-HIV activity of aryl-2-[(4-cyanophenyl)amino]-4-pyrimidinone hydrazones as potent non-nucleoside reverse transcriptase inhibitors.
December 2011, ChemMedChem,
Yuan-Zhen Xiong, and Hai-Rong Hu, and Fen-Er Chen, and Jan Balzarini, and Christophe Pannecouque, and Erik de Clercq
Non-nucleoside HIV reverse transcriptase inhibitors, Part 6[1]: synthesis and anti-HIV activity of novel 2-[(arylcarbonylmethyl)thio]-6-arylthio DABO analogues.
October 2005, Archiv der Pharmazie,
Yuan-Zhen Xiong, and Hai-Rong Hu, and Fen-Er Chen, and Jan Balzarini, and Christophe Pannecouque, and Erik de Clercq
Aryl Substituted Benzimidazolones as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors.
February 2019, ACS medicinal chemistry letters,
Yuan-Zhen Xiong, and Hai-Rong Hu, and Fen-Er Chen, and Jan Balzarini, and Christophe Pannecouque, and Erik de Clercq
Molecular Modeling, Synthesis, and Anti-HIV Activity of Novel Isoindolinedione Analogues as Potent Non-nucleoside Reverse Transcriptase Inhibitors.
February 2016, Chemical biology & drug design,
Yuan-Zhen Xiong, and Hai-Rong Hu, and Fen-Er Chen, and Jan Balzarini, and Christophe Pannecouque, and Erik de Clercq
In silico design, synthesis and anti-HIV activity of quinoline derivatives as non-nucleoside reverse transcriptase inhibitors (NNRTIs).
June 2022, Computational biology and chemistry,
Copied contents to your clipboard!